The current gold standard for the diagnosis and treatment of solid tumors is the collection of a tissue biopsy from the tumor site. Mutation tracking in tumor DNA and the prediction of the risk of metastatic relapse is a challenge in modern cancer therapy.

The investigation of liquid biopsies from whole blood samples is a promising new and noninvasive way to determine the required information for cancer management. Besides the analysis of circulating tumor DNA (ctDNA) the isolation and identification of circulating tumor cells (CTCs) has increasingly come into focus in this context.

ABF (Member of GBAGroupPharma) is the best choice when it comes to clinical trial logistics that require a controlled coldchain delivery. ABF relies only on hand-picked and qualified transportation companies such as World Courier. We have been working together for over 10 years with great success with ever increasing quality standards. Even during the COVID-19 pandemic, we have and are still delivering in time.

With Regulation (EU) 2020/770, new MRLs have been established for the pesticide sintofen in or on certain products e.g. nuts. The GBA Group has established an analytical method particularly to meet the residue definition of phenoxyalkanecarboxylic acids. As a producer, ensure the food safety of your products with our service.

Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.

The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.

Hamburg/Stuttgart, April 6th, 2021. INSTITUT PIELDNER - Dienstleistungsinstitut für Lebens-mittelqualität GmbH (INSTITUT PIELDNER), located in Stuttgart, has been part of the GBA Group since the year 2017. In anticipation of the further expansion of the location, INSTITUT PIELDNER has now merged with GBA Gesellschaft für Bioanalytik mbH (GBA). The Stuttgart location will continue to function as a center of competence for the analysis of food, environment, and drinking water, with a wide spectrum of laboratory analyses and consulting services. The GBA location in Stuttgart has expanded its service portfolio particularly in terms of soil and water analysis, such as with the coordination and implementation of accredited sampling of drinking water, pool water, and cooling water, as well as comprehensive digital project management.